Logo image of NRC.OL

NRC GROUP ASA (NRC.OL) Stock Fundamental Analysis

OSL:NRC - Euronext Oslo - NO0003679102 - Common Stock - Currency: NOK

5.12  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NRC. NRC was compared to 39 industry peers in the Construction & Engineering industry. NRC may be in some trouble as it scores bad on both profitability and health. NRC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NRC had positive earnings in the past year.
In the past year NRC had a positive cash flow from operations.
In the past 5 years NRC reported 4 times negative net income.
Each year in the past 5 years NRC had a positive operating cash flow.
NRC.OL Yearly Net Income VS EBIT VS OCF VS FCFNRC.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M -800M

1.2 Ratios

NRC's Return On Assets of -21.70% is on the low side compared to the rest of the industry. NRC is outperformed by 94.87% of its industry peers.
NRC has a Return On Equity of -58.42%. This is amonst the worse of the industry: NRC underperforms 94.87% of its industry peers.
Industry RankSector Rank
ROA -21.7%
ROE -58.42%
ROIC N/A
ROA(3y)-9.33%
ROA(5y)-5.9%
ROE(3y)-24.21%
ROE(5y)-15.19%
ROIC(3y)N/A
ROIC(5y)N/A
NRC.OL Yearly ROA, ROE, ROICNRC.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NRC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NRC.OL Yearly Profit, Operating, Gross MarginsNRC.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

NRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NRC has been increased compared to 1 year ago.
NRC has more shares outstanding than it did 5 years ago.
NRC has a better debt/assets ratio than last year.
NRC.OL Yearly Shares OutstandingNRC.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NRC.OL Yearly Total Debt VS Total AssetsNRC.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

NRC has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
NRC has a Debt to Equity ratio (0.45) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.94%
NRC.OL Yearly LT Debt VS Equity VS FCFNRC.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 1.01 indicates that NRC should not have too much problems paying its short term obligations.
The Current ratio of NRC (1.01) is comparable to the rest of the industry.
A Quick Ratio of 1.00 indicates that NRC should not have too much problems paying its short term obligations.
The Quick ratio of NRC (1.00) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 1
NRC.OL Yearly Current Assets VS Current LiabilitesNRC.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

NRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 110.00%, which is quite impressive.
NRC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 53.06% yearly.
The Revenue has been growing slightly by 2.39% in the past year.
NRC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.21% yearly.
EPS 1Y (TTM)110%
EPS 3YN/A
EPS 5Y53.06%
EPS Q2Q%-775%
Revenue 1Y (TTM)2.39%
Revenue growth 3Y1.44%
Revenue growth 5Y16.21%
Sales Q2Q%-3.5%

3.2 Future

Based on estimates for the next years, NRC will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.92% on average per year.
Based on estimates for the next years, NRC will show a small growth in Revenue. The Revenue will grow by 3.61% on average per year.
EPS Next Y-1190.8%
EPS Next 2Y-19.6%
EPS Next 3Y12.77%
EPS Next 5Y16.92%
Revenue Next Year1.46%
Revenue Next 2Y1.21%
Revenue Next 3Y2.72%
Revenue Next 5Y3.61%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NRC.OL Yearly Revenue VS EstimatesNRC.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
NRC.OL Yearly EPS VS EstimatesNRC.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.24, the valuation of NRC can be described as very reasonable.
76.92% of the companies in the same industry are more expensive than NRC, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of NRC to the average of the S&P500 Index (28.79), we can say NRC is valued rather cheaply.
The Price/Forward Earnings ratio is 15.84, which indicates a correct valuation of NRC.
Based on the Price/Forward Earnings ratio, NRC is valued a bit more expensive than the industry average as 61.54% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 21.38. NRC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 10.24
Fwd PE 15.84
NRC.OL Price Earnings VS Forward Price EarningsNRC.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

97.44% of the companies in the same industry are more expensive than NRC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.24
NRC.OL Per share dataNRC.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

NRC's earnings are expected to grow with 12.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.19
EPS Next 2Y-19.6%
EPS Next 3Y12.77%

More info and screens

0

5. Dividend

5.1 Amount

NRC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NRC GROUP ASA

OSL:NRC (4/25/2025, 7:00:00 PM)

5.12

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-12 2025-02-12/bmo
Earnings (Next)05-16 2025-05-16
Inst Owners17.38%
Inst Owner ChangeN/A
Ins Owners0.35%
Ins Owner ChangeN/A
Market Cap885.50M
Analysts74.29
Price Target5.1 (-0.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2086.89%
Min EPS beat(2)-2674.26%
Max EPS beat(2)-1499.51%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.45%
Min Revenue beat(2)5.72%
Max Revenue beat(2)13.19%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)65.33%
EPS NY rev (1m)-60.74%
EPS NY rev (3m)-69.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE 10.24
Fwd PE 15.84
P/S 0.13
P/FCF N/A
P/OCF 28.56
P/B 0.52
P/tB N/A
EV/EBITDA 2.24
EPS(TTM)0.5
EY9.77%
EPS(NY)0.32
Fwd EY6.31%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.18
OCFY3.5%
SpS39.86
BVpS9.89
TBVpS-0.81
PEG (NY)N/A
PEG (5Y)0.19
Profitability
Industry RankSector Rank
ROA -21.7%
ROE -58.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-9.33%
ROA(5y)-5.9%
ROE(3y)-24.21%
ROE(5y)-15.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.5
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 1.15
Cap/Depr 5.81%
Cap/Sales 0.71%
Interest Coverage N/A
Cash Conversion 4.6%
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 1
Altman-Z N/A
F-Score4
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)10.19%
Cap/Depr(5y)10.53%
Cap/Sales(3y)0.63%
Cap/Sales(5y)0.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110%
EPS 3YN/A
EPS 5Y53.06%
EPS Q2Q%-775%
EPS Next Y-1190.8%
EPS Next 2Y-19.6%
EPS Next 3Y12.77%
EPS Next 5Y16.92%
Revenue 1Y (TTM)2.39%
Revenue growth 3Y1.44%
Revenue growth 5Y16.21%
Sales Q2Q%-3.5%
Revenue Next Year1.46%
Revenue Next 2Y1.21%
Revenue Next 3Y2.72%
Revenue Next 5Y3.61%
EBIT growth 1Y-261.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year205.03%
EBIT Next 3Y50.69%
EBIT Next 5YN/A
FCF growth 1Y-105.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-91.76%
OCF growth 3Y-55.76%
OCF growth 5Y-15.27%